RNASE3 and cholesteryl ester measurement: In conclusion, based on the significant decrease of ECP serum levels after operative and/or BMZ treatment in AE and CE patients and its correlation with tracer uptake in PET–CTI in AE patients, it is recommended to investigate ECP more intensively as a marker of AE and CE in prospective studies with larger cohorts.